Cita APA

Jeannot, V., Busser, B., Vanwonterghem, L., Michallet, S., Ferroudj, S., Cokol, M., . . . Hurbin, A. (2016). Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma. Onco Targets Ther.

Chicago Style Citation

Jeannot, Victor, Benoit Busser, Laetitia Vanwonterghem, Sophie Michallet, Sana Ferroudj, Murat Cokol, Jean-Luc Coll, Mehmet Ozturk, i Amandine Hurbin. "Synergistic Activity of Vorinostat Combined With Gefitinib but Not With Sorafenib in Mutant KRAS Human Non-small Cell Lung Cancers and Hepatocarcinoma." Onco Targets Ther 2016.

Cita MLA

Jeannot, Victor, et al. "Synergistic Activity of Vorinostat Combined With Gefitinib but Not With Sorafenib in Mutant KRAS Human Non-small Cell Lung Cancers and Hepatocarcinoma." Onco Targets Ther 2016.